Pelthos Therapeutics Inc., a Nevada company incorporated on March 19, 2021. The company is a clinical-stage biotechnology company focused on developing and commercializing new therapies for pain relief. The company's clinical focus is selectively targeting sodium ion channels, known as "NaV 1.7," as well as other receptors in the NaV family. NaV 1.7 has been genetically validated as a pain receptor in human physiology. Genetic studies have shown that families with some kind of hereditary NaV 1.7 regulation consistently show a pathology of not feeling pain. 

Pelthos Therapeutics' 15-minute chart has recently experienced a KDJ Death Cross and a Bearish Marubozu at 09/11/2026 15:45. This indicates a shift in momentum towards the downside, with potential for further decreases in the stock price. Sellers are currently in control of the market, and the bearish momentum is likely to persist.On September 11, 2026, Pelthos Therapeutics' 15-minute chart recorded a KDJ Death Cross and a Bearish Marubozu at 15:45, signaling a potential shift in momentum toward the downside[1]. These technical indicators suggest that sellers are currently in control, with bearish pressure likely to persist in the near term. The KDJ Death Cross typically indicates weakening momentum, while the Bearish Marubozu reinforces the likelihood of continued downward movement in the stock price. Investors should remain cautious as these patterns often precede further declines. While technical analysis does not guarantee future price movements, the convergence of these signals highlights a period of increased bearish sentiment. Market participants are advised to monitor subsequent price action and volume for confirmation of the trend. As always, a comprehensive investment strategy should incorporate both technical and fundamental analysis, along with an assessment of broader market conditions.

Pelthos Therapeutics's 15min chart signals bearish trend with KDJ Death Cross and Marubozu.

The 15-minute chart for Pelthos Therapeutics has recently exhibited a MACD Death Cross, coupled with a Bearish Marubozu pattern on November 11, 2026, at 2:15 PM. This indicates that the stock price is poised to continue its downward trajectory, with sellers dominating the market and reinforcing bearish momentum.Pelthos Therapeutics Inc. (PTHS) has recently shown bearish technical signals on its 15-minute chart, raising concerns among traders. On November 11, 2026, at 2:15 PM, the stock formed a Bearish Marubozu pattern, a candlestick formation typically associated with strong selling pressure and a lack of buyer participation. This pattern was accompanied by a MACD Death Cross, indicating <a href="https://www.google.com/goto?url=CAESZgHrOzAV0FOW_bCYFyD3ikAnvnFYiDnkfUg2W-LFNXj8RB1WyisrlvyHXY4jO0Doh9pItv5QxE1XzT4ytPpn0TP7qM0uBO-49s8nZHxKC_w5rMK4A4vwmyz9Qea_C3P7NRveAb4vFQ">a potential shift in momentum</a> toward the downside.The stock’s technical indicators continue to reflect a bearish outlook. The Moving Averages Convergence Divergence (MACD) indicator is currently at -0.988, reinforcing <a href="https://www.google.com/goto?url=CAESZgHrOzAV0FOW_bCYFyD3ikAnvnFYiDnkfUg2W-LFNXj8RB1WyisrlvyHXY4jO0Doh9pItv5QxE1XzT4ytPpn0TP7qM0uBO-49s8nZHxKC_w5rMK4A4vwmyz9Qea_C3P7NRveAb4vFQ">a Strong Sell signal</a>. Additionally, PTHS is trading below its 20-day ($25.491), 60-day ($26.828), and 200-day ($25.295) moving averages, further <a href="https://www.google.com/goto?url=CAESZgHrOzAV0FOW_bCYFyD3ikAnvnFYiDnkfUg2W-LFNXj8RB1WyisrlvyHXY4jO0Doh9pItv5QxE1XzT4ytPpn0TP7qM0uBO-49s8nZHxKC_w5rMK4A4vwmyz9Qea_C3P7NRveAb4vFQ">supporting the bearish bias</a>.Key support levels to monitor include $21.885 and $19.492, while resistance is expected at $26.875. A break below the immediate support level could signal further downward movement. Investors are advised to closely watch these levels as well as the RSI, which currently stands at 34.011, indicating <a href="https://www.google.com/goto?url=CAESZgHrOzAV0FOW_bCYFyD3ikAnvnFYiDnkfUg2W-LFNXj8RB1WyisrlvyHXY4jO0Doh9pItv5QxE1XzT4ytPpn0TP7qM0uBO-49s8nZHxKC_w5rMK4A4vwmyz9Qea_C3P7NRveAb4vFQ">a neutral market condition</a>.

Pelthos Therapeutics' 15min chart: MACD Death Cross, Bearish Marubozu signal detected.

Pelthos Therapeutics' 15-minute chart has recently exhibited a significant bullish trend, with the KDJ indicator crossing into a "golden cross" formation at 09:00 on November 11, 2026. This technical indicator suggests a notable shift in momentum towards the upside, with the potential for further price increases. The bullish marubozu candlestick pattern also reinforces this optimistic outlook, as it indicates strong buying pressure and control of the market by buyers. As a result, it is likely that the bullish momentum will continue, and investors may consider taking a long position in the stock.Pelthos Therapeutics' 15-minute chart has recently displayed a significant bullish trend, marked by a "golden cross" formation of the KDJ indicator at 09:00 on November 11, 2026. This technical signal is often interpreted as a potential turning point in momentum, suggesting a shift toward upward movement in the stock's price. Additionally, the appearance of a bullish marubozu candlestick pattern further supports this interpretation. The marubozu, characterized by a large body and minimal or absent wicks, indicates <a href="https://www.google.com/goto?url=CAES3QEB6zswFeO_jKvi2gMfhzpT5VlVbMjzsObGLRSMhdaoeffhQq4aLwU0FmBXfQcqFUCur3z4ClrSZUZNsyNWbXBDxi-ANh_dzSyeP8Z6NdhYOiKdHgemyGnuWXc21UY7V0SUjeySm0sWDTLIJqMbPQRDM7zw3saOKlk4NXsZCcxHA_5SbaeXb7N3cQvYw4snPYSE5jXCtiA6bXMLJVzibim1MEizeMQbIxUSQH7V3kN2JkumhWmSjA545qqezgn2goc_8ULQpXZl2BH741CPF-QjDR8Yn4y2V3D2ae__0Q">strong buying pressure and control</a> by buyers throughout the trading period. These technical signals collectively suggest a continuation of bullish momentum in the near term. Investors monitoring the stock may consider these patterns as part of a broader technical analysis framework when evaluating potential long positions. As with all intraday signals, confirmation through subsequent price action and broader market conditions should be taken into account before making investment decisions.

Pelthos Therapeutics' 15min chart sees KDJ Golden Cross, Bullish Marubozu formation.

Pelthos Therapeutics' 15-minute chart has exhibited a KDJ Death Cross, accompanied by a Bearish Marubozu at 09/10/2026 12:30. This suggests a shift in momentum towards a downward trajectory, with potential for further decline. Sellers currently dominate the market, and it is likely that bearish momentum will persist.Pelthos Therapeutics (PTX) has recently shown bearish technical signals that may indicate a potential downward trend in its stock price. On September 10, 2026, at 12:30 PM, the stock formed a Bearish Marubozu candlestick pattern, suggesting strong selling pressure and a lack of buyer participation during the period[1]. Concurrently, the KDJ indicator displayed a Death Cross, a technical formation often interpreted as a sign of weakening momentum and a possible continuation of the downward trend[2]. These signals collectively suggest that sellers are currently in control, and the stock may face further downward movement in the near term. Investors are advised to monitor the stock closely for confirmation of the trend and to consider their risk exposure accordingly. As with all technical indicators, these signals should be used in conjunction with broader market analysis and fundamental evaluation to make informed investment decisions.

Pelthos Therapeutics: KDJ Death Cross and Bearish Marubozu Indicate Bearish Trend.

Pelthos Therapeutics' 15-minute chart has recently triggered two technical indicators, RSI Oversold and KDJ Golden Cross, both of which occurred on September 10, 2026 at 11:45. These indicators suggest that the stock price has declined rapidly and fallen below its fundamental support level, indicating a potential shift in momentum towards the upside. As a result, there is a potential for the stock price to continue increasing.On September 10, 2026, Pelthos Therapeutics Inc. (PTHS) experienced notable activity on its 15-minute chart, with two technical indicators—RSI Oversold and KDJ Golden Cross—triggering at 11:45. These signals suggest a rapid decline in the stock price, which has fallen below its fundamental support level, potentially <a href="https://www.google.com/goto?url=CAESXQHrOzAVRrdOZUW6faM9dFbQdjpt4keaSxkUdA5GioO2qd-vXc-ls0JLsPNsxzQ5Hy7-ulwYgRqyNFfBzKAkyDnDV5_XFzUzMlXhvBF_o2RXfqgX1VryWi2a_vBMHA">indicating a shift in momentum</a> toward the upside. Year-to-date, PTHS has delivered a total return of 26.74%, outperforming the S&amp;P 500’s 11.07% return over the same period. Over the past three and five years, PTHS has returned 62.15% and 62.15%, respectively, compared to <a href="https://www.google.com/goto?url=CAESXQHrOzAVRrdOZUW6faM9dFbQdjpt4keaSxkUdA5GioO2qd-vXc-ls0JLsPNsxzQ5Hy7-ulwYgRqyNFfBzKAkyDnDV5_XFzUzMlXhvBF_o2RXfqgX1VryWi2a_vBMHA">S&amp;P 500’s 70.57% and 70.53%</a>. While historical performance does not guarantee future results, the recent technical signals may suggest a potential continuation of the upward trend. Investors are advised to consider these indicators in conjunction with broader market conditions and company fundamentals before making investment decisions.

PTHS News